Monica Surgicals And Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 11.82%
- Profit Growth 18.36%
- Ebitda -18.80%
- Net Worth 4.82%
- Total Assets 4.73%
About Monica Surgicals And Pharma
Monica Surgicals And Pharma Private Limited (MSAPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 July 2017 (Seven years and six months 16 days old ). Its registered office is in Madurai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Dileep Arulpragasam and Thomas Rajasekar serve as directors at the Company.
Company Details
-
Location
Madurai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999TN2017PTC117636
-
Company No.
117636
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Jul 2017
-
Date of AGM
26 Jul 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Monica Surgicals And Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dileep Arulpragasam
|
Managing Director | 18-Jul-2017 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Thomas Rajasekar
|
Director | 18-Jul-2017 | Current |
Financial Performance of Monica Surgicals And Pharma.
Monica Surgicals And Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.82% increase. The company also saw a substantial improvement in profitability, with a 18.36% increase in profit. The company's net worth moved up by a moderate rise of 4.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Monica Surgicals And Pharma?
In 2020, Monica Surgicals And Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sunmed Health Care Private LimitedDileep Arulpragasam is a mutual person
-
Chendur Printers Private Limited
Thomas Rajasekar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Monica Surgicals And Pharma?
Unlock and access historical data on people associated with Monica Surgicals And Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Monica Surgicals And Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Monica Surgicals And Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.